CURE 360: Attacking Rett Syndrome from Every Angle | Rett Syndrome Research Trust |
|
There is now an eighth biopharmaceutical program pursuing a cure for Rett syndrome! Neurogene has announced that they are pursuing a gene replacement program for Rett, and we have added Neurogene to our CURE 360 plan.
CURE 360 is the Rett Syndrome Research Trust's plan to cure Rett syndrome. This plan, the only one in existence for Rett, encompasses our vision, singular focus, deep understanding of the science, the environment we’ve built for collaboration, and our experience with drug and business development. The plan is executed by our staff and advisors who are driven and fearless, and who refuse to be distracted by anything that doesn’t move the needle toward a cure. Learn more: https://reverserett.org/research/ --------------------------------- The Rett Syndrome Research Trust is singularly focused on a cure for Rett syndrome and related MECP2 disorders. Achieving success takes a deep understanding of the relevant science, an environment built for scientific collaboration, and experience with drug and business development. Today we are building on incredible scientific and industry momentum by implementing six genetic-based strategies that tackle Rett from every angle. Every single company pursuing a cure for Rett is able to do so because they leveraged discoveries and resources that were generated with RSRT funding. RSRT is the home of the Rett cure community, and we are confident that together we will cure Rett syndrome. |